These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19451502)

  • 1. A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy.
    Gebhardt C; Averbeck M; Paasch U; Ugurel S; Kurzen H; Stumpp P; Simon JC; Treudler R
    Arch Dermatol; 2009 May; 145(5):571-4. PubMed ID: 19451502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.
    Utikal J; Ugurel S; Kurzen H; Erben P; Reiter A; Hochhaus A; Nebe T; Hildenbrand R; Haberkorn U; Goerdt S; Schadendorf D
    Arch Dermatol; 2007 Jun; 143(6):736-40. PubMed ID: 17576939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated Rosai-Dorfman disease of intracranial meninges.
    Z'Graggen WJ; Sturzenegger M; Mariani L; Keserue B; Kappeler A; Vajtai I
    Pathol Res Pract; 2006; 202(3):165-70. PubMed ID: 16377100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.
    Heinrich MC; Joensuu H; Demetri GD; Corless CL; Apperley J; Fletcher JA; Soulieres D; Dirnhofer S; Harlow A; Town A; McKinley A; Supple SG; Seymour J; Di Scala L; van Oosterom A; Herrmann R; Nikolova Z; McArthur AG;
    Clin Cancer Res; 2008 May; 14(9):2717-25. PubMed ID: 18451237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. May 2003: 57-year-old-woman with acute loss of strength in her right upper extremity and slurred speech.
    Castellano-Sanchez AA; Brat DJ
    Brain Pathol; 2003 Oct; 13(4):641-2, 645. PubMed ID: 14655768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Rosai-Dorfman disease.
    Merola JF; Pulitzer M; Rosenman K; Brownell I
    Dermatol Online J; 2008 May; 14(5):8. PubMed ID: 18627744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous rosai-dorfman disease: a clinical and histopathologic study of 25 cases in China.
    Kong YY; Kong JC; Shi DR; Lu HF; Zhu XZ; Wang J; Chen ZW
    Am J Surg Pathol; 2007 Mar; 31(3):341-50. PubMed ID: 17325475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous rosai-dorfman disease and morphea: coincidence or association?
    Chappell JA; Burkemper NM; Frater JL; Hurley MY
    Am J Dermatopathol; 2009 Jul; 31(5):487-9. PubMed ID: 19542928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Rosai-Dorfman disease.
    Rubenstein MA; Farnsworth NN; Pielop JA; Orengo IF; Curry JL; Drucker CR; Hsu S
    Dermatol Online J; 2006 Jan; 12(1):8. PubMed ID: 16638376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous revelation of Rosai-Dorfman disease: 7 cases].
    Vuong V; Moulonguet I; Cordoliani F; Crickx B; Bezier M; Vignon-Pennamen MD; Flageul B; Bagot M; Petit A
    Ann Dermatol Venereol; 2013 Feb; 140(2):83-90. PubMed ID: 23395488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosai-Dorfman disease and juvenile xanthogranuloma in a Thai boy: report of a case.
    Poklang V; Shuangshoti S; Chaipipat M; Nuchprayoon I; Shuangshoti S
    J Med Assoc Thai; 2006 Jan; 89(1):94-8. PubMed ID: 16583588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Rosai-Dorfman disease.
    Khoo JJ; Rahmat BO
    Malays J Pathol; 2007 Jun; 29(1):49-52. PubMed ID: 19105329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial removal of orbital tumor in Rosai-Dorfman disease.
    Wu SY; Ma L; Tsai YJ
    Jpn J Ophthalmol; 2004; 48(2):154-7. PubMed ID: 15060795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate.
    Ogawa Y; Kawamura T; Furuhashi M; Tsukamoto K; Shimada S
    J Dermatol Sci; 2008 Sep; 51(3):190-9. PubMed ID: 18485676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan.
    Lu CI; Kuo TT; Wong WR; Hong HS
    J Am Acad Dermatol; 2004 Dec; 51(6):931-9. PubMed ID: 15583585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
    Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
    Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal Rosai-Dorfman Disease presenting as an epibulbar tumor.
    Fernandes BF; Brazuna A; Moura LR; Ayres B; Nakamura P; Al-Kandari AA; Burnier MN
    Cornea; 2008 Apr; 27(3):378-81. PubMed ID: 18362675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rosai-Dorfman disease limited to the skin. Four case reports].
    Ortiz-Hidalgo C; Cuesta-Mejías TC; Ochoa-Ochoa C; Valenzuela-Espinosa A; Toussaint-Caire S
    Gac Med Mex; 2003; 139(1):1-6. PubMed ID: 12666403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
    Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
    Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure secondary to imatinib mesylate treatment in prostate cancer.
    Foringer JR; Verani RR; Tjia VM; Finkel KW; Samuels JA; Guntupalli JS
    Ann Pharmacother; 2005 Dec; 39(12):2136-8. PubMed ID: 16288076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.